BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 32127012)

  • 1. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis.
    Li J; Wang Y; Wang X; Yang Q
    World J Surg Oncol; 2020 Mar; 18(1):50. PubMed ID: 32127012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation.
    Wang N; Zhang H; Li D; Jiang C; Zhao H; Teng Y
    Bioengineered; 2021 Dec; 12(2):12431-12446. PubMed ID: 34895070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cell division cycle 20 as a candidate biomarker and potential therapeutic target in bladder cancer using bioinformatics analysis.
    Shen P; He X; Lan L; Hong Y; Lin M
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The identification of a common different gene expression signature in patients with colorectal cancer.
    Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
    Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening of differentially expressed genes for colorectal cancer and prediction of potential traditional Chinese medicine: based on bioinformatics].
    Yun ZJ; Wang HJ; Yu YX; Sun ZY; Yao SK
    Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(6):1666-1676. PubMed ID: 35347966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
    Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
    Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
    Hammad A; Elshaer M; Tang X
    Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
    Chen J; Wang Z; Shen X; Cui X; Guo Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
    Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
    J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.
    Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X
    Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics-based identification of key genes and pathways associated with colorectal cancer diagnosis, treatment, and prognosis.
    Wang C; Zhang L
    Medicine (Baltimore); 2022 Sep; 101(37):e30619. PubMed ID: 36123948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
    Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
    Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.